Narhimed Closed Nose Decongestant Nasal Spray 10 ml

€11.05
Tax included
Minsan
015598028
100% secure payments
Hurry up! Only 14 item(s) left in Stock!
Quantity

WARNINGS
The drug, like other sympathomimetic agents, should be used with caution in patients who show a strong reaction to adrenergic substances manifesting as signs of insomnia, dizziness, tremor, cardiac arrhythmia or high blood pressure. Like other vasoconstrictors for local use, the medicine should not be used for more 'than 7 consecutive days: prolonged or excessive use can cause rebound congestion and / or atrophy of the nasal mucosa. Do not exceed the indicated doses, especially in the elderly. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus, pheochromocytoma as well as in patients with prostatic hypertrophy and in patients treated with monoamine oxidase inhibitors (MAOIs) or who have taken them in the last two weeks. The product contains benzalkonium chloride (BAC) as a preservative which, especially when used for long periods, can cause swelling of the nasal mucosa. If such a reaction (persistent nasal congestion) is suspected, a nasal medicine without benzalkonium chloride should be used if possible. If such medicines for nasal use without benzalkonium chloride are not available, another pharmaceutical form should be considered. It can cause bronchospasm.
PHARMACOTHERAPEUTIC CATEGORY
Nasal decongestants and other topical preparations.
STORAGE
Store at a temperature below 30 degrees C; store in the original packaging.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity to xylometazoline or to any of the listed excipients; closed-angle glucoma; chronic rhinitis; patients with dry or atrophic rhinitis; pregnancy; children under the age of 12. Like other vasoconstrictors, do not use the drug in patients undergoing transphenoidal hypophysectomy or surgery with exposure of the dura mater.
NAME
NARHIMED CLOSED NOSE
EXCIPIENTS
Nasal drops, solution - Nasal spray, solution: monobasic sodium phosphate dihydrate; disodium phosphate dodecahydrate; sodium edetate; benzalkonium chloride; sorbitol 70%; hypromellose; sodium chloride; purified water.
SIDE EFFECTS
Adverse reactions are listed by organ system classification and frequency. Frequencies are defined as: very common (> = 1/10); common (> = 1/100 to <1/10); uncommon (> = 1 / 1,000 to <1/100); rare (> = 1 / 10,000 to <1 / 1,000) or very rare (<1 / 10,000). Disorders of the immune system. Very rare: hypersensitivity reactions' (angioedema, rash, pruritus). Nervous system disorders. Common: headache. Eye disorders. Very rare: transient visual disturbances Cardiac disorders. Very rare: irregular heart rate and increased heart rate. Respiratory, thoracic and mediastinal disorders. Common: nasal dryness or discomfort. Gastrointestinal disorders. Common: nausea. General disorders and administration site conditions. Common: burning at the application site. Other side effects found: arterial hypertension, reflex bradycardia, urination disturbances, insomnia and restlessness. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.
PREGNANCY AND BREASTFEEDING
In view of its potential systemic vasoconstrictive effect, it is advisable to take the precaution not to use the medicinal product during pregnancy. There is no evidence of adverse effects on the breastfed infant. However, it is not known whether xylometazoline is excreted in breast milk, therefore caution should be used and the medicine should only be used during breastfeeding under medical advice. There are no adequate data on the effects of the drug on fertility 'and no animal studies are available. Since systemic exposure to xylometazoline hydrochloride is very low, effects on fertility are therefore very unlikely.
INDICATIONS
Decongestant of the nasal mucosa (in case of cold, hay fever or other allergic rhinitis, sinusitis).
INTERACTIONS
Monoamine oxidase inhibitors (MAOIs): xylometazoline can enhance the action of monoamine oxidase inhibitors and can cause hypertensive crisis. Xylometazoline is not recommended in patients who are taking or have taken MAOIs within the past two weeks. Tricyclic and tetracyclic antidepressants: the concomitant use of tricyclic and tetracyclic antidepressants and sympathomimetics may reinforce the sympathomimetic effect of xylometazoline and is therefore not recommended.
DOSAGE
The use of the medicine is limited to adults and adolescents (between 12 and 18 years of age). Nasal drops, solution: instill 2-3 drops of the solution in each nostril 1-3 times a day, as needed. Do not exceed 3 applications in each anarch per day. Nasal spray, solution: 1 spray, 1-3 times per day, as needed. Do not exceed 3 applications in each nostril per day. >> Method of administration. Nasal drops, solution: clean the nose; recline your head back in a comfortable position or, if lying in bed, bow your head to the side; instill the drops in each nostril and keep the head tilted back for a while to allow the drops to spread into the nose; immediately after use, clean and dry the dropper before putting it back in the bottle. To avoid the possible spread of infection, the bottle is for use by one person only. Nasal spray, solution: Before using the spray for the first time, press the pump by triggering it a few times until a uniform mist is emitted. At subsequent applications, the dosing pump will be ready for immediate use. For administration follow the instructions below, being careful not to spray the spray into the eyes. Clean your nose hold the bottle upright with the thumb under the base and the spout between the two fingers; lean slightly forward and insert the nozzle into one nostril; spray and at the same time breathe gently through the nose; immediately after use, clean and dry the dispenser before replacing the cap. To avoid the possible spread of infections, each spray pack should be used by one person only. Pediatric population: the medicine should not be used in children younger 'less than 12 years.
ACTIVE PRINCIPLES
Xylometazoline hydrochloride.
015598028
14 Items

Specific References

chat Comments (0)
No customer reviews for the moment.

Narhimed Closed Nose...

€11.05